Doctors Enroute Dr NP Veliotes 082 451 2810

Recent technological developments have made it possible to detect Oxygen Consumption Rate OCR in living cells during the course of an experiment in a long-term, high-throughput manner. This ability can offer fresh perspectives on how cells divide, metabolise, differentiate, and react to stress in dynamic environments.

This white paper offers a thorough overview of OCR normalisation techniques, including as flow cytometry, protein-based, DNA content, and microscopy methods. In order to account for factors and uncover significant differences from your data, it discusses both internal and external normalisation strategies. Your lab can improve the accuracy of OCR measurements and gain a better understanding of mitochondrial function and its role in both health and illness.

A study from Cold Spring Harbor Laboratory suggests that a vitamin K precursor, menadione, may offer a highly targeted way to kill prostate cancer cells.

Unlike traditional treatments that push cancer into dormancy, menadione acts as a pro-oxidant, disrupting a key lipid called PI(3)P. This lipid helps cells manage waste, and without it, cancer cells become overwhelmed and ultimately burst.

The study, published in Science, demonstrated significant tumor suppression in both mice and human cancer cells. Researchers believe this method could offer a safer and more definitive resolution for prostate cancer while minimizing the risk of resistance.

Beyond cancer, menadione also shows promise in treating X-linked myotubular myopathy, a severe genetic muscle disorder. Importantly, menadione’s safety profile appears favorable, as it is commonly used in animal feed to support vitamin K production.

The findings suggest that menadione could be especially beneficial for prostate cancer patients under active surveillance, potentially delaying or even preventing progression.

With low side effects and a highly selective approach, this research offers new hope for effective, minimally invasive cancer treatment options.

Scientists have discovered a new way to detect Alzheimer’s disease by studying how the brain’s oxygen supply and nerve activity interact.

A study found that people with Alzheimer’s have a significantly higher resting breathing rate—about 17 breaths per minute compared to 13 in healthy individuals. This surprising discovery suggests that breathing patterns could serve as an early warning sign of the disease, possibly linked to brain inflammation.

Led by researchers at Lancaster University, the study focused on the neurovascular unit (NVU), a system that ensures the brain gets enough oxygen and nutrients. The NVU consists of blood vessels, brain cells called astrocytes, and neurons working together to maintain brain function. To analyze how this system is affected by Alzheimer’s, researchers used a non-invasive approach, measuring brain electrical activity, blood oxygen levels, heart rate, and breathing patterns. Participants wore electrical and optical probes on their scalp, an ECG measured heart activity, and a chest belt monitored breathing.

By studying these physiological rhythms, researchers discovered that Alzheimer’s patients showed weaker coordination between brain signals and oxygen flow, indicating poor blood supply regulation. This breakdown in neurovascular function could contribute to brain degeneration seen in Alzheimer’s. Using mathematical models, scientists analyzed the “power” and “phase coherence” of these biological rhythms, revealing clear differences between healthy individuals and those with Alzheimer’s.

The study suggests that Alzheimer’s may not just be a brain disorder but also a vascular one, where blood flow issues play a key role in disease progression. Since drug trials targeting brain proteins have shown limited success, scientists believe focusing on the vascular system and NVU could lead to more effective treatments.

This method is simple, inexpensive, and non-invasive, making it a promising tool for early detection. Researchers are now exploring ways to turn these findings into a widely available test, possibly through a spin-off company. If further studies confirm these results, monitoring breathing patterns and neurovascular function could revolutionize Alzheimer’s diagnosis and treatment.